About the Event
Spire Health has developed an unobtrusive, state-of-the-art wearable device that monitors a COPD patient’s respiration. It already has FDA approval and there are 3,400 patients using their technology today.
Join this webinar with Spire Health President and CEO, Mike Doyle, to learn how their AI-powered device saves payers thousands and why they’ve already attracted the interest of major health organizations including Kaiser Permanente and Asaar Medical.